RDH12 Fund for Sight is a brand dedicated to bringing together families affected by Leber Congenital Amaurosis (LCA) caused by RDH12 mutations. Their mission is to collect and distribute information about this specific form of LCA, while also ensuring that significant funds are allocated towards research and development for treatments. The fund has already awarded research grants amounting to over $500,000 and has raised nearly $1,000,000 to support the cure.

In 2014, the fund recognized the work of Dr. Debra Thompson at the University of Michigan for her groundbreaking gene therapy. The brand's story began in 2010 when four families met at an LCA conference and realized that they shared a common genetic cause.

Determined to find a cure and prevent their children from losing their sight, they established the RDH12 Fund for Sight. They continue to reach out to more families, creating a supportive community focused on sharing resources, knowledge, and experiences. By donating to the cause, you can contribute to finding a cure for all those affected by RDH12 and help provide a future of sight for these children